Ali Bukhari

531 total citations
25 papers, 297 citations indexed

About

Ali Bukhari is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Ali Bukhari has authored 25 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 4 papers in Surgery and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Ali Bukhari's work include CAR-T cell therapy research (14 papers), Lymphoma Diagnosis and Treatment (4 papers) and Cancer Genomics and Diagnostics (3 papers). Ali Bukhari is often cited by papers focused on CAR-T cell therapy research (14 papers), Lymphoma Diagnosis and Treatment (4 papers) and Cancer Genomics and Diagnostics (3 papers). Ali Bukhari collaborates with scholars based in United States, United Kingdom and Saudi Arabia. Ali Bukhari's co-authors include Saurabh Dahiya, Aaron P. Rapoport, Noa G. Holtzman, Jean A. Yared, Nancy M. Hardy, Jay Y. Spiegel, Crystal L. Mackall, Nasheed Hossain, Lik Wee Lee and Frederick L. Locke and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The American Journal of Gastroenterology.

In The Last Decade

Ali Bukhari

21 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ali Bukhari United States 9 206 70 45 45 45 25 297
Marc Hoffmann United States 10 209 1.0× 106 1.5× 77 1.7× 25 0.6× 25 0.6× 58 428
Lisa Wray United States 10 271 1.3× 28 0.4× 61 1.4× 68 1.5× 47 1.0× 22 398
Emma Grigor Canada 7 143 0.7× 11 0.2× 35 0.8× 38 0.8× 23 0.5× 21 265
Chelsea Kotch United States 4 131 0.6× 28 0.4× 59 1.3× 23 0.5× 8 0.2× 13 315
George Hucks United States 7 302 1.5× 39 0.6× 82 1.8× 97 2.2× 8 0.2× 11 359
Lamis Eldjerou United States 10 178 0.9× 23 0.3× 29 0.6× 45 1.0× 5 0.1× 22 260
David M. Cordas dos Santos Germany 8 251 1.2× 25 0.4× 82 1.8× 34 0.8× 5 0.1× 16 304
Uri Greenbaum Israel 9 117 0.6× 27 0.4× 37 0.8× 23 0.5× 5 0.1× 26 232
Alison Humphreys United Kingdom 6 98 0.5× 28 0.4× 66 1.5× 12 0.3× 7 0.2× 16 311

Countries citing papers authored by Ali Bukhari

Since Specialization
Citations

This map shows the geographic impact of Ali Bukhari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Bukhari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Bukhari more than expected).

Fields of papers citing papers by Ali Bukhari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Bukhari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Bukhari. The network helps show where Ali Bukhari may publish in the future.

Co-authorship network of co-authors of Ali Bukhari

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Bukhari. A scholar is included among the top collaborators of Ali Bukhari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Bukhari. Ali Bukhari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alshaikh, Husain N., Mohammed S. Alqahtani, Ali Bukhari, et al.. (2025). Antithrombotic resumption after middle meningeal artery embolization or surgery for chronic subdural hematoma: a systematic review and meta-analysis. Journal of NeuroInterventional Surgery. 18(2). 468–477.
2.
3.
Malik, Asad Waqar, et al.. (2023). Do Platelet-Rich Plasma Injections for Knee Osteoarthritis Work?. Cureus. 15(2). e34533–e34533. 6 indexed citations
4.
5.
Frank, Matthew J., Nasheed Hossain, Ali Bukhari, et al.. (2021). Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymphoma: Results of a Prospective Multi-Institutional Trial. Journal of Clinical Oncology. 39(27). 3034–3043. 87 indexed citations
6.
Holtzman, Noa G., Hao Xie, Søren M. Bentzen, et al.. (2020). Immune effector cell–associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy for lymphoma: predictive biomarkers and clinical outcomes. Neuro-Oncology. 23(1). 112–121. 71 indexed citations
7.
Lutfi, Forat, Noa G. Holtzman, Ali Bukhari, et al.. (2020). Chimeric antigen receptor T‐cell therapy after allogeneic stem cell transplant for relapsed/refractory large B‐cell lymphoma. British Journal of Haematology. 192(1). 212–216. 15 indexed citations
8.
Lutfi, Forat, Ali Bukhari, David Gottlieb, et al.. (2020). Detailed Immunophenotypic Profiling of Peripheral Blood Immune Cells in Patients with Hematologic Malignancies after Sars-Cov-2 Infection. Blood. 136(Supplement 1). 32–32.
9.
Holtzman, Noa G., Ali Bukhari, Matthew Brown, et al.. (2020). Toxoplasma‐induced hemophagocytic lymphohistiocytosis after haploidentical allogeneic stem cell transplantation. Transplant Infectious Disease. 22(2). e13242–e13242. 6 indexed citations
10.
Lutfi, Forat, Ali Bukhari, Noa G. Holtzman, et al.. (2020). Pseudo-Allogeneic CAR-T Therapy after Allogeneic Stem Cell Transplantation in Relapsed/Refractory B-Cell NHL. Blood. 136(Supplement 1). 22–23. 5 indexed citations
11.
Lutfi, Forat, Ankit Kansagra, Moaath K. Mustafa Ali, et al.. (2020). The Impact of Bridging Therapy Prior to CAR-T Cell Therapy on Clinical Outcomes of Patients with Relapsed Refractory Large B-Cell Lymphoma. Blood. 136(Supplement 1). 7–8. 1 indexed citations
12.
13.
Bukhari, Ali, Saurabh Dahiya, Olga Goloubeva, et al.. (2019). Pattern of Use and Outcomes with Donor Lymphocyte Infusion (DLI) and Unmanipulated Stem Cell Boost (SCB) after Allogeneic Hematopoietic Stem Cell Transplant (HSCT): A Single-Center Experience. Biology of Blood and Marrow Transplantation. 25(3). S250–S251.
14.
Frank, Matthew J., Nasheed Hossain, Ali Bukhari, et al.. (2019). Detectable Circulating Tumor DNA 28 Days after the CD19 CAR T-Cell Therapy, Axicabtagene Ciloleucel, Is Associated with Poor Outcomes in Patients with Diffuse Large B-Cell Lymphoma. Blood. 134(Supplement_1). 884–884. 14 indexed citations
15.
Frank, Matthew J., Nasheed Hossain, Ali Bukhari, et al.. (2019). Monitoring ctDNA in r/r DLBCL patients following the CAR T-cell therapy axicabtagene ciloleucel: Day 28 landmark analysis.. Journal of Clinical Oncology. 37(15_suppl). 7552–7552. 6 indexed citations
16.
Sirous, Reza, Ali Bukhari, Firas El Chaer, et al.. (2019). Early imaging biomarker assessment to predict long-term responses for large B-cell lymphoma (LBCL) after CAR-T therapy.. Journal of Clinical Oncology. 37(15_suppl). 7560–7560. 3 indexed citations
17.
Bukhari, Ali, et al.. (2017). Timeliness of Lung Cancer Diagnosis and Treatment.. PubMed. 34(Suppl 1). 24S–29S. 2 indexed citations
18.
Bukhari, Ali, et al.. (2014). Culture Negative Neutrocytic Ascites in a Severe Clostridium Difficile Infection. The American Journal of Gastroenterology. 109. S404–S405. 1 indexed citations
19.
Bukhari, Ali & Ranjit K. Goudar. (2013). Thymidylate Synthase as a Predictive Biomarker for Pemetrexed Response in NSCLC. PubMed. 2013. 1–7. 8 indexed citations
20.
Bukhari, Ali, et al.. (2011). Strategies to Promote High School Students’ Healthful Food Choices. Journal of Nutrition Education and Behavior. 43(5). 414–418. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marc Hoffmann Breakdown of academic impact, for papers by Lisa Wray Breakdown of academic impact, for papers by Emma Grigor Breakdown of academic impact, for papers by Chelsea Kotch Breakdown of academic impact, for papers by George Hucks Breakdown of academic impact, for papers by Lamis Eldjerou Breakdown of academic impact, for papers by David M. Cordas dos Santos Breakdown of academic impact, for papers by Uri Greenbaum Breakdown of academic impact, for papers by Alison Humphreys
Rankless by CCL
2026